Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $8.0 million.

  • Nuvation Bio's Share-based Compensation rose 729.0% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 4760.93%. This contributed to the annual value of $32.3 million for FY2024, which is 6540.26% up from last year.
  • Latest data reveals that Nuvation Bio reported Share-based Compensation of $8.0 million as of Q3 2025, which was up 729.0% from $12.0 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Share-based Compensation peaked at $12.0 million during Q2 2025, and registered a low of $3.7 million during Q4 2023.
  • Over the past 3 years, Nuvation Bio's median Share-based Compensation value was $7.5 million (recorded in 2024), while the average stood at $7.2 million.
  • Over the last 5 years, Nuvation Bio's Share-based Compensation had its largest YoY gain of 17375.07% in 2024, and its largest YoY loss of 421.75% in 2024.
  • Over the past 3 years, Nuvation Bio's Share-based Compensation (Quarter) stood at $3.7 million in 2023, then surged by 173.75% to $10.2 million in 2024, then dropped by 21.28% to $8.0 million in 2025.
  • Its Share-based Compensation stands at $8.0 million for Q3 2025, versus $12.0 million for Q2 2025 and $7.9 million for Q1 2025.